The Navigator - Navigenics Blog

Genetic insights into health and wellness

All results for "Medication responses we analyze" (2)

July 14, 2010

Taking some of the guesswork out of warfarin

Posted 02:00 PM PDT

imageIt’s one of the more common prescription drugs, but until you need warfarin, you may have never heard of it. Sold under brand names including Coumadin® and Waran®, this blood thinner is prescribed millions of times a year in the United States to help treat or prevent blood clots. If you are undergoing major surgery, or experiencing conditions such as an irregular heartbeat or DVT (deep vein thrombosis), your doctor is likely to prescribe warfarin or another blood thinner.

But even though warfarin is common, it isn’t always easy to use. Finding the right dose for any one person is tricky, and the process often begins with trial and error. Too little of the drug, and a person can still experience a dangerous blood clot. Too much warfarin, and a person can suffer hazardous bouts of uncontrolled bleeding. Some of this individual response depends on personal genetics. Safe, effective warfarin use requires carefully calculated personalized dosing, and personal genetic information can be a helpful part of that equation.

At Navigenics, we recently launched a new Medications service, which provides personalized genetic information to help you understand which prescription drugs may work best for you. Warfarin is one of 12 medications analyzed in this feature of our service. The warfarin-related genetic results we provide can be used by your doctor to help calculate an individualized warfarin dose, using tools such as the calculator provided by www.WarfarinDosing.org.

This week, we enhanced our warfarin results further by providing an even more specific explanation of what they mean for personal warfarin dosing. 

Read More

Categories: Medication responses we analyze, Warfarin sensitivity

| Email Post | Comments (0) | Permalink

April 28, 2010

Looking for new answers on Plavix and personal genetics

Posted 04:43 PM PDT

imagePlavix®, a prescription drug that helps prevent and treat blood clots, is one of the world’s top-selling medications. According to its manufacturer, doctors have prescribed it to more than 100 million people.Yet, genetics shows, popularity doesn’t always mean that a drug works for everyone.

And when it comes to Plavix®, that fact has some scientists working to see how genetic testing can provide better answers for people who take this medication.

Some people, because of their genetic makeup, don’t process Plavix® as effectively as others, leaving them vulnerable to dangerous blood clotting problems. In March, the U.S. Food and Drug Administration revised the drug label on Plavix® (also known by its generic name clopidogrel), emphasizing that people who carry certain genetic variants may not benefit fully from the drug. The FDA announcement also stressed that testing is available for a gene linked to a reduced response to Plavix®.

Since the vast majority of people who’ve taken Plavix® have never undergone genetic testing, researchers are now analyzing the ways that genetic insights can help.

Read More

Categories: Medication responses we analyze, Clopidogrel (Plavix) effectiveness

| Email Post | Comments (0) | Permalink